Citation Impact
Citing Papers
Potent Induction of Tumor Immunity by Combining Tumor Cryoablation with Anti–CTLA-4 Therapy
2011 StandoutNobel
Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial
2007 Standout
Dendritic Cell Targeting of Survivin Protein in a Xenogeneic Form Elicits Strong CD4+ T Cell Immunity to Mouse Survivin
2006 StandoutNobel
Serum-Soluble B7x Is Elevated in Renal Cell Carcinoma Patients and Is Associated with Advanced Stage
2008 StandoutNobel
Efficient T Cell Activation via a Toll-Interleukin 1 Receptor-Independent Pathway
2006 StandoutNobel
The Transcription Factor Myc Controls Metabolic Reprogramming upon T Lymphocyte Activation
2011 Standout
Immunosuppressive networks in the tumour environment and their therapeutic relevance
2005 Standout
Small-Vessel Vasculitis
1997 Standout
mRNA-based therapeutics — developing a new class of drugs
2014 StandoutNobel
Toll-like receptor control of the adaptive immune responses
2004 Standout
Effector and memory T-cell differentiation: implications for vaccine development
2002 Standout
Coordinated regulation of myeloid cells by tumours
2012 Standout
Anti-neutrophil cytoplasmic antibodies: Current diagnostic and pathophysiological potential
1994
The interface between innate and adaptive immunity
2004 StandoutNobel
Commitment to the Regulatory T Cell Lineage Requires CARMA1 in the Thymus but Not in the Periphery
2009 StandoutNobel
Fcγ receptors as regulators of immune responses
2007 Standout
Evolution of a designed protein assembly encapsulating its own RNA genome
2017 StandoutNatureNobel
Thermal ablation of tumours: biological mechanisms and advances in therapy
2014 Standout
Precis on forward genetics in mice
2007 StandoutNobel
Non-viral vectors for gene-based therapy
2014 Standout
Toll-like receptor signalling
2004 Standout
Graves' Ophthalmopathy
2010 Standout
An IFN-γ-IL-18 Signaling Loop Accelerates Memory CD8+ T Cell Proliferation
2008 StandoutNobel
IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction
2005 Standout
Engineering targeted viral vectors for gene therapy
2007
The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses
2004 Standout
Photodynamic therapy and anti-tumour immunity
2006 Standout
Strategies for immunotherapy of cancer
2000
The immunological consequences of photodynamic treatment of cancer, a literature review
2003
Metabolomics: beyond biomarkers and towards mechanisms
2016 Standout
The immune contexture in human tumours: impact on clinical outcome
2012 Standout
Applications of CRISPR technologies in research and beyond
2016 StandoutNobel
B7-H4 (DD-O110) is overexpressed in high risk uterine endometrioid adenocarcinomas and inversely correlated with tumor T-cell infiltration
2007
Naïve CTLs require a single brief period of antigenic stimulation for clonal expansion and differentiation
2001
The Unc93b1 mutation 3d disrupts exogenous antigen presentation and signaling via Toll-like receptors 3, 7 and 9
2006 StandoutNobel
CRISPR-Based Technologies for the Manipulation of Eukaryotic Genomes
2016 Standout
Lineage relationship and protective immunity of memory CD8 T cell subsets
2003 Standout
The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling
2007 Standout
Upregulation of costimulatory molecules induced by lipopolysaccharide and double-stranded RNA occurs by Trif-dependent and Trif-independent pathways
2003 StandoutNobel
Inferences, questions and possibilities in Toll-like receptor signalling
2004 StandoutNatureNobel
Immune system and prognosis in colorectal cancer: a detailed immunohistochemical analysis
2004
Dynamic programming of CD8+ T lymphocyte responses
2003
Selective Modification of Antigen-Specific T Cells by RNA Electroporation
2008
Adenovirus-Mediated Somatic Genome Editing of Pten by CRISPR/Cas9 in Mouse Liver in Spite of Cas9-Specific Immune Responses
2015
The Unexpected Importance of the Primary Structure of the Hydrophobic Part of One-Component Ionizable Amphiphilic Janus Dendrimers in Targeted mRNA Delivery Activity
2022 StandoutNobel
VASCULITIS IN CHILDREN AND ADOLESCENTS
1995
Synergy between In situ Cryoablation and TLR9 Stimulation Results in a Highly Effective In vivo Dendritic Cell Vaccine
2006
Impact of Immune Parameters on Long-Term Survival in Metastatic Renal Cell Carcinoma
2006
Insight into Graves’ Hyperthyroidism from Animal Models
2005
Comparative analysis of NK cell subset distribution in normal and lymphoproliferative disease of granular lymphocyte conditions
2004
Immune Complex-Loaded Dendritic Cells Are Superior to Soluble Immune Complexes as Antitumor Vaccine
2006
TYPE I INTERFERONS (α/β) IN IMMUNITY AND AUTOIMMUNITY
2004 StandoutNobel
Optimal induction of effector but not memory antitumor cytotoxic T lymphocytes involves direct antigen presentation by the tumor cells.
2001
Cell intrinsic mechanisms of T‐cell inhibition and application to cancer therapy
2008 StandoutNobel
Immune-Mediated Inhibition of Metastases after Treatment with Local Radiation and CTLA-4 Blockade in a Mouse Model of Breast Cancer
2005 StandoutNobel
Nanoparticles in Photodynamic Therapy
2015 Standout
Synergism of Cytotoxic T Lymphocyte–Associated Antigen 4 Blockade and Depletion of Cd25+ Regulatory T Cells in Antitumor Therapy Reveals Alternative Pathways for Suppression of Autoreactive Cytotoxic T Lymphocyte Responses
2001 StandoutNobel
Cross-priming of CTL responses in vivo does not require antigenic peptides in the endoplasmic reticulum of immunizing cells.
1998
Prognostic Factors for Overall Survival in Patients With Metastatic Renal Cell Carcinoma Treated With Vascular Endothelial Growth Factor–Targeted Agents: Results From a Large, Multicenter Study
2009 Standout
Central Memory and Effector Memory T Cell Subsets: Function, Generation, and Maintenance
2004 Standout
Essential role of mda-5 in type I IFN responses to polyriboinosinic:polyribocytidylic acid and encephalomyocarditis picornavirus
2006 StandoutNobel
B7-H3 and B7x are highly expressed in human prostate cancer and associated with disease spread and poor outcome
2007 StandoutNobel
NK cell–mediated killing of target cells triggers robust antigen-specific T cell–mediated and humoral responses
2009 StandoutNobel
Distinctive NK-cell receptor repertoires sustain high-level constitutive NK-cell activation in HIV-exposed uninfected individuals
2007 StandoutNobel
GENETIC ANALYSIS OF HOST RESISTANCE: Toll-Like Receptor Signaling and Immunity at Large
2006 StandoutNobel
Generation of antitumor immunity by cytotoxic T lymphocyte epitope peptide vaccination, CpG-oligodeoxynucleotide adjuvant, and CTLA-4 blockade.
2003
HIV-1-infected monocyte-derived dendritic cells do not undergo maturation but can elicit IL-10 production and T cell regulation
2004 StandoutNobel
Cutting Edge: A Crucial Role for B7-CD28 in Transmitting T Help from APC to CTL
2002 StandoutNobel
Innate NKT lymphocytes confer superior adaptive immunity via tumor-capturing dendritic cells
2005 StandoutNobel
Works of Liesbeth E. Jonges being referenced
The Phenotypic Heterogeneity of Human Natural Killer Cells: Presence of at least 48 Different Subsets in the Peripheral Blood
2001
A basal membrane-like structure surrounding tumour nodules may prevent intraepithelial leucocyte infiltration in colorectal cancer
2003
Caspase-3 Activity as a Prognostic Factor in Colorectal Carcinoma
2001
Recombinant adenoviral vectors have adjuvant activity and stimulate T cell responses against tumor cells
2000
Tumor structure and extracellular matrix as a possible barrier for therapeutic approaches using immune cells or adenoviruses in colorectal cancer
2000
IgA antibodies directed against cytoplasmic antigens of polymorphonuclear leukocytes in patients with Henoch-Schoenlein purpura.
1987
Role of NK cells in adoptive immunotherapy of metastatic colorectal cancer in a syngeneic rat model
2001
Efficient direct priming of tumor-specific cytotoxic T lymphocyte in vivo by an engineered APC.
1998